[Drug interaction behind the toxicity of chemotherapy].
Laine
K
K
TYKS:n kliinisen farmakologian yksikkö 20520 Turku. karlai@utu.fi
Valavaara
R
R
Rouru
J
J
D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000378:metabolism; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications / Q000188:drug therapy* / Q000532:radiotherapy; D008297:Male; D013280:Stomatitis / Q000139:chemically induced; D014700:Verapamil / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D003577:Cytochrome P-450 Enzyme System; D014700:Verapamil